Bio-Techne (TECH) Form 4: Bohnen increases holdings via options, sells 527 shares
Rhea-AI Filing Summary
Shane Bohnen, SVP – General Counsel of Bio-Techne Corp (TECH), reported multiple option exercises, restricted stock unit vesting events and a small sale on 08/15/2025. The Form 4 shows a non-derivative acquisition of 1,718 shares (transaction code M) at $0 and a sale of 527 shares at $53.60, leaving 4,385 shares beneficially owned after the sale. The filing details many derivative holdings: several stock options exercisable at strike prices from $47.60 to $120.46, totaling tens of thousands of underlying shares, plus multiple restricted stock unit and performance award pools. Notable items include exercises or acquisitions that increased holdings by large blocks of shares via option-related transactions and performance awards that vest on future dates if goals are met.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider executed option-related transactions increasing equity exposure while also selling a small block of shares.
The report indicates active equity compensation activity for a senior executive: acquisitions (including option-related acquisitions coded M and multiple award grants/vests) materially increase the executive's potential equity stake through tens of thousands of underlying shares. The 527-share disposition at $53.60 is modest relative to overall derivative holdings. The schedule of strikes and vesting dates shows a multi-year compensation runway, which can dilute or align incentives depending on future vesting and exercise behavior.
TL;DR: Filing documents routine executive compensation events and a minor open-market sale; no governance red flags disclosed.
Transactions appear to be standard equity compensation exercises, vesting, and performance-based awards for a named officer who is also a director. The presence of performance-conditioned awards and staggered vesting schedules is consistent with typical retention and performance alignment practices. The document does not disclose any related-party unusual arrangements or departures from standard grant terms.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 50 | $0.00 | -- |
| Exercise | Restricted Stock Units | 1,668 | $0.00 | -- |
| Grant/Award | Performance Restricted Stock Units | 13,992 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 6,996 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 17,897 | $0.00 | -- |
| Exercise | Common Stock | 1,718 | $0.00 | -- |
| Tax Withholding | Common Stock | 527 | $53.60 | $28K |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Performance Stock Option (Right to Buy) | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Footnotes (1)
- Fully exercisable. Options to purchase 876 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026, and options to purchase 880 shares vest on 8/15/2024. Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. 2,259 restricted stock units vest on 4/3/2026. Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027. 49 restricted stock units vest on 8/15/2026. Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027. Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). 2,332 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. Options to purchase 5,966 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 5,965 shares vest on 8/15/2028.
